Canada markets closed

PharmaCielo Ltd. (PCLO.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.20500.0000 (0.00%)
At close: 03:59PM EDT

PharmaCielo Ltd.

82 Richmond Street East
Toronto, ON M5C 1P1
Canada

https://www.pharmacielo.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Marc Lustig M.B.A., M.Sc.Chairman & CEO57.5kN/A1974
Mr. Ian D. Atacan B.Sc., C.M.A., C.P.A., M.B.A.CFO, Corporate Secretary & Director275kN/AN/A
Mr. Andres Felipe BoteroChief Operating Officer290.57kN/AN/A
Dr. Decio Rabelo de Castro FilhoChief Medical OfficerN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. The company also offers telemedicine software. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia. PharmaCielo Ltd. has strategic partnership with Benuvia Operations, LLC to manufacture cGMP pharmaceutical-grade CBD isolate and related products. PharmaCielo Ltd. is headquartered in Toronto, Canada.

Corporate Governance

PharmaCielo Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.